Current location: Home > Applications > Immune Cell Culture-related Proteins > Recombinant Human TNFα

Recombinant Human TNFα

Recombinant Human TNFα

Cat#:Y04401

Species:Human

Size:10μg/50μg/1mg

Purity:≥95%

Endotoxin: ≤10 EU/mg

Application Details

General description

Tumor Necrosis Factor Alpha is a pleiotropic pro-inflammatory cytokine that regulates immune responses, cell survival, and apoptosis. It is a master regulator of inflammation and a therapeutic target in autoimmune diseases. Recombinant Human TNF-α Protein (Y04401) is expressed from mammalian cells. It contains AA Val 77 - Leu 233 (Accession # P01375), and is widely used in advanced cell culture, immunology research, and inflammatory disease modeling.


Application

· Macrophage and Monocyte Activation — Induces classical activation and pro-inflammatory cytokine production.

· NF-κB and Inflammation Signaling Research — Models TNF-α-driven inflammatory gene expression pathways.

· Apoptosis and Necroptosis Studies — Investigates cell death mechanisms through TNFR1 and TNFR2 signaling.

· Intestinal Organoid Barrier Dysfunction — Induces inflammatory phenotypes mimicking Crohn's disease and colitis.

· Serum-Free Culture Systems — Suitable for chemically defined and xeno-free cell culture media.


Product Specifications

Cat. No.Y04401
Purity≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining).
Endotoxin≤10 EU/mg by the LAL method.
BioactivityMeasured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 for this effect is 5-60 pg/mL.
AccessionP01375
Alternative Namesumor Necrosis Factor; Cachectin; TNF-Alpha; Tumor Necrosis Factor Ligand Superfamily Member 2; TNF-a; TNF; TNFA; TNFSF2
SpeciesHuman
Expression SystemCHO
Mol. Weight17.4 kDa
Expression RegionVal77-Leu233
Tag InfoTag free
FormulationLyophilized
BufferPBS, 5% Mannitol and 0.01% Tween 80, pH7.4.
Lead TimeProducts are in stock, but custom products may require further consultation.
ShippingThe product is shipped with blue ice.


Stability and Reconstitution

· 36 months at -20°C to -80°C in lyophilized state;

· 6 months at -20°C to -80°C under sterile conditions after reconstitution;

· 7-10 days at 2°C to 8°C under sterile conditions after reconstitution;

· Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

· It is recommended to redissolve in sterile deionized water.


Backgroud

TNF-α is produced primarily by activated macrophages and signals through TNFR1 and TNFR2, activating NF-κB, MAPK, and death domain pathways. It is a central mediator of acute and chronic inflammation, with therapeutic antibodies (infliximab, adalimumab, etanercept) revolutionizing the treatment of rheumatoid arthritis, inflammatory bowel disease, and psoriasis. In cell culture, TNF-α is used to activate macrophages, model inflammatory signaling, study cell death pathways, and induce barrier dysfunction in intestinal organoids.


Q&A

Q1: What is TNF-α mainly used for?

TNF-α is primarily used for macrophage activation, inflammation signaling research, apoptosis studies, and intestinal organoid modeling.


Q2: Is this TNF-α suitable for serum-free culture systems?

Yes. EastMabBio recombinant TNF-α is compatible with serum-free, xeno-free, and chemically defined media systems.


Q3: How should recombinant TNF-α be stored?

Lyophilized protein should be stored at -20°C or below. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.


Q4: What shipping conditions are used?

Products are shipped on dry ice with validated cold-chain packaging to maintain stability during international transportation.


Q5: Do you provide QC documents?

Yes. COA, MSDS, TSE-BSE statements, endotoxin reports, bioactivity data, and additional QC documentation are available upon request.


Data
SDS-PAGE
image.png

Recombinant Human TNFα (Cat. No. Y04401) was analyzed by SDS-PAGE.

Bioactivity
Y04401-1.jpg

Recombinant Human TNFα (Cat. No. Y04401) measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 for this effect is 5-60 pg/mL. The bioactivity of Y04401 was equivalent to other competing products.

Bioactivity
Y04401-2.jpg

Measured in a cytotoxicity assay using L‑929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D.

SEC-HPLC
image.png


Enquire Now
  • Research Field:
  • Our customer service specialist will contact you via email within 24 hours, please check your email address
EastMabBio
Provide high-quality recombinant protein raw materials to the world
Contact Us

+86-400-998-0106

product@eastmab.com

Jiangsu East-Mab Bio:Building 13 and 17, 888 Zhujiang Road, Rudong, Nantong, Jiangsu 226499 , China

Suzhou East-Mab Bio:Floor 5 & 6, Building 1, 168 Majian Road, Suzhou, Jiangsu 215129, China

Contact Us

Recently Viewed
EastMabBio
Quality Management System
Privacy Policy
×

Platform Information Submission-Privacy Agreement

· Privacy Policy

No content yet



Laws and regulations
×

Platform Information Statement-Laws and Regulations

· Laws and regulations

Trademark registration of Jiangsu Dongkang Biomedical Technology Co., Ltd.  

East Mab

East Mab Bio

东抗生物